IRF2 deficiency disrupts pyroptosis, NK cell interferon-γ production and resistance to Francisella

Read full text
Authors: Maxence Cornut, Sophia Djebali, Elena Rondeau, Sarah Dayet, Théo Fayolle, Julie Haagen, Lucie Fallone, Noëmi Rousseaux, Emmanuelle Caspar, Mélissa Marcotte, Amandine Martin, Elise Courteboeuf
+8 more Maëlan Deschamps-Biboulet, Marie Teixeira, Jacqueline Marvel, Bénédicte F. Py, Thierry Walzer, Antoine Marçais, Thomas Henry, Emilie Bourdonnay
Cited by: 0
References: 62

Abstract

Abstract IRF2 plays an indirect role in inflammasome activation by regulating Caspase-4 and Gasdermin D (GSDMD) levels. However, the in vivo relevance of this regulatory circuit is unknown. We generate IRF2 KO mice and demonstrate that they are equally susceptible to Francisella novicida infection as GSDMD KO mice. Interestingly, the phenotypes of IRF2 KO and GSDMD KO mice diverge with respect to IFN-γ. Specifically, IRF2 KO mice exhibit a profound defect in IFN-γ production, which we attribute to an intrinsic role of IRF2 in regulating both the number and maturation of NK cells. IRF2 KO NK cells fail to express the antibacterial effectors IL-18R and Granzyme A, thereby impairing bacterial clearance. IFN-γ therapy partially restores immune responses in IRF2 KO mice and resistance to infection. These findings confirm IRF2 as a dual regulator of inflammasome activity and NK cell function, highlighting its pivotal role in innate immunity. Moreover, they underscore the potential of IFN-γ therapy as a promising treatment for severe infections in patients with primary immunodeficiencies affecting multiple immune pathways.

Fields of Study & Subjects

Inflammasome and immune disorders interferon and immune responses Immune Response and Inflammation

Publication details

Journal / source
EMBO Reports
Volume
27
Issue
5
Pages
1325–1352
Publication date
28 January 2026
Language
EN